217 related articles for article (PubMed ID: 29499955)
1. A Sensitive In Vitro Approach to Assess the Hybridization-Dependent Toxic Potential of High Affinity Gapmer Oligonucleotides.
Dieckmann A; Hagedorn PH; Burki Y; Brügmann C; Berrera M; Ebeling M; Singer T; Schuler F
Mol Ther Nucleic Acids; 2018 Mar; 10():45-54. PubMed ID: 29499955
[TBL] [Abstract][Full Text] [Related]
2. Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcripts.
Burel SA; Hart CE; Cauntay P; Hsiao J; Machemer T; Katz M; Watt A; Bui HH; Younis H; Sabripour M; Freier SM; Hung G; Dan A; Prakash TP; Seth PP; Swayze EE; Bennett CF; Crooke ST; Henry SP
Nucleic Acids Res; 2016 Mar; 44(5):2093-109. PubMed ID: 26553810
[TBL] [Abstract][Full Text] [Related]
3. Antiviral Efficacy of RNase H-Dependent Gapmer Antisense Oligonucleotides against Japanese Encephalitis Virus.
Okamoto S; Echigoya Y; Tago A; Segawa T; Sato Y; Itou T
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834294
[TBL] [Abstract][Full Text] [Related]
4. Hsp90 protein interacts with phosphorothioate oligonucleotides containing hydrophobic 2'-modifications and enhances antisense activity.
Liang XH; Shen W; Sun H; Kinberger GA; Prakash TP; Nichols JG; Crooke ST
Nucleic Acids Res; 2016 May; 44(8):3892-907. PubMed ID: 26945041
[TBL] [Abstract][Full Text] [Related]
5. RNA Reduction and Hepatotoxic Potential Caused by Non-Gapmer Antisense Oligonucleotides.
Hori SI; Mitsuoka Y; Kugimiya A
Nucleic Acid Ther; 2019 Feb; 29(1):44-50. PubMed ID: 30508397
[TBL] [Abstract][Full Text] [Related]
6. Ribonuclease H1-dependent hepatotoxicity caused by locked nucleic acid-modified gapmer antisense oligonucleotides.
Kasuya T; Hori S; Watanabe A; Nakajima M; Gahara Y; Rokushima M; Yanagimoto T; Kugimiya A
Sci Rep; 2016 Jul; 6():30377. PubMed ID: 27461380
[TBL] [Abstract][Full Text] [Related]
7. Structure Activity Relationships of α-L-LNA Modified Phosphorothioate Gapmer Antisense Oligonucleotides in Animals.
Seth PP; Jazayeri A; Yu J; Allerson CR; Bhat B; Swayze EE
Mol Ther Nucleic Acids; 2012 Sep; 1(10):e47. PubMed ID: 23344239
[TBL] [Abstract][Full Text] [Related]
8. Acute hepatotoxicity of 2' fluoro-modified 5-10-5 gapmer phosphorothioate oligonucleotides in mice correlates with intracellular protein binding and the loss of DBHS proteins.
Shen W; De Hoyos CL; Sun H; Vickers TA; Liang XH; Crooke ST
Nucleic Acids Res; 2018 Mar; 46(5):2204-2217. PubMed ID: 29390093
[TBL] [Abstract][Full Text] [Related]
9. Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index.
Shen W; De Hoyos CL; Migawa MT; Vickers TA; Sun H; Low A; Bell TA; Rahdar M; Mukhopadhyay S; Hart CE; Bell M; Riney S; Murray SF; Greenlee S; Crooke RM; Liang XH; Seth PP; Crooke ST
Nat Biotechnol; 2019 Jun; 37(6):640-650. PubMed ID: 31036929
[TBL] [Abstract][Full Text] [Related]
10. Selection, optimization, and pharmacokinetic properties of a novel, potent antiviral locked nucleic acid-based antisense oligomer targeting hepatitis C virus internal ribosome entry site.
Laxton C; Brady K; Moschos S; Turnpenny P; Rawal J; Pryde DC; Sidders B; Corbau R; Pickford C; Murray EJ
Antimicrob Agents Chemother; 2011 Jul; 55(7):3105-14. PubMed ID: 21502629
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the effect of 2'-O-methyl, fluoro hexitol, bicyclo and Morpholino nucleic acid modifications on potency of GalNAc conjugated antisense oligonucleotides in mice.
Prakash TP; Yu J; Kinberger GA; Low A; Jackson M; Rigo F; Swayze EE; Seth PP
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3774-3779. PubMed ID: 30342955
[TBL] [Abstract][Full Text] [Related]
12. Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals.
Swayze EE; Siwkowski AM; Wancewicz EV; Migawa MT; Wyrzykiewicz TK; Hung G; Monia BP; Bennett CF
Nucleic Acids Res; 2007; 35(2):687-700. PubMed ID: 17182632
[TBL] [Abstract][Full Text] [Related]
13. An Investigation into the Potential of Targeting
Goddard LR; Mardle CE; Gneid H; Ball CG; Gowers DM; Atkins HS; Butt LE; Watts JK; Vincent HA; Callaghan AJ
Molecules; 2021 Jun; 26(11):. PubMed ID: 34200016
[TBL] [Abstract][Full Text] [Related]
14. The intratracheal administration of locked nucleic acid containing antisense oligonucleotides induced gene silencing and an immune-stimulatory effect in the murine lung.
Uemura Y; Hagiwara K; Kobayashi K
PLoS One; 2017; 12(11):e0187286. PubMed ID: 29107995
[TBL] [Abstract][Full Text] [Related]
15. Identification of nucleobase chemical modifications that reduce the hepatotoxicity of gapmer antisense oligonucleotides.
Yoshida T; Morihiro K; Naito Y; Mikami A; Kasahara Y; Inoue T; Obika S
Nucleic Acids Res; 2022 Jul; 50(13):7224-7234. PubMed ID: 35801870
[TBL] [Abstract][Full Text] [Related]
16. Quantitative fluorescence imaging determines the absolute number of locked nucleic acid oligonucleotides needed for suppression of target gene expression.
Buntz A; Killian T; Schmid D; Seul H; Brinkmann U; Ravn J; Lindholm M; Knoetgen H; Haucke V; Mundigl O
Nucleic Acids Res; 2019 Jan; 47(2):953-969. PubMed ID: 30462278
[TBL] [Abstract][Full Text] [Related]
17. Comparison of hepatic transcription profiles of locked ribonucleic acid antisense oligonucleotides: evidence of distinct pathways contributing to non-target mediated toxicity in mice.
Kakiuchi-Kiyota S; Koza-Taylor PH; Mantena SR; Nelms LF; Enayetallah AE; Hollingshead BD; Burdick AD; Reed LA; Warneke JA; Whiteley LO; Ryan AM; Mathialagan N
Toxicol Sci; 2014 Mar; 138(1):234-48. PubMed ID: 24336348
[TBL] [Abstract][Full Text] [Related]
18. Sequence motifs associated with hepatotoxicity of locked nucleic acid--modified antisense oligonucleotides.
Burdick AD; Sciabola S; Mantena SR; Hollingshead BD; Stanton R; Warneke JA; Zeng M; Martsen E; Medvedev A; Makarov SS; Reed LA; Davis JW; Whiteley LO
Nucleic Acids Res; 2014 Apr; 42(8):4882-91. PubMed ID: 24550163
[TBL] [Abstract][Full Text] [Related]
19. Phospholamban Inhibition by a Single Dose of Locked Nucleic Acid Antisense Oligonucleotide Improves Cardiac Contractility in Pressure Overload-Induced Systolic Dysfunction in Mice.
Morihara H; Yamamoto T; Oiwa H; Tonegawa K; Tsuchiyama D; Kawakatsu I; Obana M; Maeda M; Mohri T; Obika S; Fujio Y; Nakayama H
J Cardiovasc Pharmacol Ther; 2017 May; 22(3):273-282. PubMed ID: 27811197
[TBL] [Abstract][Full Text] [Related]
20. Development of gapmer antisense oligonucleotide with deoxyribonucleic guanidine (DNG) modifications.
Kojima N; Shrestha AR; Akisawa T; Piao H; Kizawa H; Ohmiya Y; Kurita R
Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):258-269. PubMed ID: 31556356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
